Uveal melanoma: Epidemiologic aspects

Ophthalmology Clinics of North America

Volumn 18, Issue 1, 2005, Pages 75-84

  Singh, Arun D ^a   Bergman, Louise ^b   Seregard, Stefan ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b ST ERIK S EYE HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL PROLIFERATION; CHROMOSOME ANALYSIS; CORRELATION ANALYSIS; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; EXPOSURE; FAMILY HISTORY; HISTOPATHOLOGY; HUMAN; INCIDENCE; MOLECULAR GENETICS; MORTALITY; OCCUPATION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SUNLIGHT; UVEA MELANOMA;

EID: 14844307061     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ohc.2004.07.002     Document Type: Review

References (73)

1. A.E. Chang, L.H. Karnell, and H.R. Menck The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society Cancer 83 8 1998 1664 1678
2. J.J. Dutton, R.L. Anderson, R.L. Schelper, J.J. Purcell, and D.T. Tse Orbital malignant melanoma and oculodermal melanocytosis: report of two cases and review of the literature Ophthalmology 91 5 1984 497 507
3. A.D. Singh, and A. Topham Incidence of uveal melanoma in the United States: 1973-1997 Ophthalmology 110 5 2003 956 961
4. D. Strickland, and J.A. Lee Melanomas of eye: stability of rates Am J Epidemiol 113 6 1981 700 702
5. Anonymous Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report no. 1 Arch Ophthalmol 108 9 1990 1268 1273
6. E. Kujala, T. Makitie, and T. Kivela Very long-term prognosis of patients with malignant uveal melanoma Invest Ophthalmol Vis Sci 44 11 2003 4651 4659
7. A.D. Singh, and A. Topham Survival rate with uveal melanoma in the United States: 1973-1997 Ophthalmology 110 5 2003 962 965
8. J. Scotto, J.F. Fraumeni Jr, and J.A. Lee Melanomas of the eye and other noncutaneous sites: epidemiologic aspects J Natl Cancer Inst 56 3 1976 489 491
9. P.K. Lommatzsch, W. Staneczek, and H. Bernt Epidemiologic study of new cases of intraocular tumors in East Germany 1961-1980 Klin Monatsbl Augenheilkd 187 6 1985 487 492
10. T. Mork Malignant melanoma of the eye in Norway: incidence, treatment and prognosis Acta Ophthalmol 39 1961 824 831
11. A.J. Swerdlow Epidemiology of eye cancer in adults in England and Wales, 1962-1977 Am J Epidemiol 118 2 1983 294 300
12. O. Jensen Malignant melanomas of the uvea in Denmark 1943-1952 Acta Ophthalmol 75 Suppl 1963 1 220
13. C.M. Vajdic, A. Kricker, M. Giblin, J. McKenzie, J. Aitken, and G. Giles Incidence of ocular melanoma in Australia from 1990 to 1998 Int J Cancer 105 1 2003 117 122
14. K. Michalova, R. Clemett, A. Dempster, J. Evans, and R.A. Allardyce Iris melanomas: are they more frequent in New Zealand? Br J Ophthalmol 85 1 2001 4 5
15. L. Bergman, S. Seregard, B. Nilsson, U. Ringborg, and B. Ragnarsson-Olding Incidence of uveal melanoma in Sweden from 1960 to 1998 Invest Ophthalmol Vis Sci 43 8 2002 2579 2583
16. J.M. Elwood, and J. Jopson Melanoma and sun exposure: an overview of published studies Int J Cancer 73 2 1997 198 203
17. K.M. Egan, J.M. Seddon, R.J. Glynn, E.S. Gragoudas, and D.M. Albert Epidemiologic aspects of uveal melanoma Surv Ophthalmol 32 4 1988 239 251
18. T. Hakulinen, L. Teppo, and E. Saxen Cancer of the eye, a review of trends and differentials World Health Stat Q 31 2 1978 143 158
19. A. Kaneko Malignant ophthalmic tumors Nippon Rinsho 51 Suppl 1993 1013 1020
20. P.K. Kuo, C.A. Puliafito, K.M. Wang, H.S. Liu, and B.F. Wu Uveal melanoma in China Int Ophthalmol Clin 22 3 1982 57 71
21. J. Biswas, S. Krishnakumar, and M.P. Shanmugam Uveal melanoma in Asian Indians: a clinicopathological study Arch Ophthalmol 120 4 2002 522 523
22. A.R. Pane, and L.W. Hirst Ultraviolet light exposure as a risk factor for ocular melanoma in Queensland, Australia Ophthalmic Epidemiol 7 3 2000 159 167
23. P. Guenel, L. Laforest, D. Cyr, J. Fevotte, S. Sabroe, and C. Dufour Occupational risk factors, ultraviolet radiation, and ocular melanoma: a case-control study in France Cancer Causes Control 12 5 2001 451 459
24. R.P. Gallagher, J.M. Elwood, J. Rootman, J.J. Spinelli, G.B. Hill, and W.J. Threlfall Risk factors for ocular melanoma. Western Canada Melanoma Study J Natl Cancer Inst 74 4 1985 775 778
25. J. Rootman, and R.P. Gallagher Color as a risk factor in iris melanoma Am J Ophthalmol 98 5 1984 558 561
26. M.A. Tucker, J.A. Shields, P. Hartge, J. Augsburger, R.N. Hoover, and J.F. Fraumeni Jr Sunlight exposure as risk factor for intraocular malignant melanoma N Engl J Med 313 13 1985 789 792
27. G.H. Kliman, J.J. Augsburger, and J.A. Shields Association between iris color and iris melanocytic lesions Am J Ophthalmol 100 4 1985 547 548
28. A.D. Singh, I.G. Rennie, S. Seregard, M. Giblin, and J. McKenzie Sunlight exposure and pathogenesis of uveal melanoma Surv Ophthalmol 49 4 2004 419 428
29. P. Dolin, A.J.E. Foss, and J.L. Hungerford Uveal melanoma: is solar ultraviolet radiation a risk factor? Ophthalmic Epidemiol 1 1 1994 27 30
30. J.M. Seddon, E.S. Gragoudas, R.J. Glynn, K.M. Egan, D.M. Albert, and P.H. Blitzer Host factors, UV radiation, and risk of uveal melanoma: a case-control study Arch Ophthalmol 108 9 1990 1274 1280
31. C. Vajdic, A. Kricker, A. Giblin, J. McKenzie, J. Aitken, and G.G. Giles Sun exposure predicts risk of ocular melanoma in Australia Int J Cancer 101 2 2002 175 182
32. E.A. Holly, D.A. Aston, D.K. Ahn, and A.H. Smith Intraocular melanoma linked to occupations and chemical exposures Epidemiology 7 1 1996 55 61
33. U.A. Ajani, J.M. Seddon, C.C. Hsieh, K.M. Egan, D.M. Albert, and E.S. Gragoudas Occupation and risk of uveal melanoma: an exploratory study Cancer 70 12 1992 2891 2900
34. D. Vagero, A.J. Swerdlow, and V. Beral Occupation and malignant melanoma: a study based on cancer registration data in England and Wales and in Sweden Br J Ind Med 47 5 1990 317 324
35. J.L. Vidal, F. Bacin, E. Albuisson, R. Rozan, L. Desjardins, and F. D'Hermies Melanoma 92: epidemiological study of uveal melanoma in France J Fr Ophtalmol 18 8-9 1995 520 528
36. M. Diener-West, B.S. Hawkins, J.A. Markowitz, and A.P. Schachat A review of mortality from choroidal melanoma-II: a meta-analysis of 5 year mortality following enucleation 1966 through 1988 Arch Ophthalmol 110 2 1992 245 250
37. S. Seregard Long-term survival after ruthenium plaque radiotherapy for uveal melanoma: a meta-analysis of studies including 1066 patients Acta Ophthalmol Scand 77 4 1999 414 417
38. S. Kroll, D.H. Char, J. Quivey, and J. Castro A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma Ophthalmology 105 11 1998 2035 2045
39. L. Bergman, S. Seregard, B. Nilsson, G. Lundell, U. Ringborg, and R. Ragnarsson-Olding Uveal melanoma survival in Sweden 1960 to 1998 Invest Ophthalmol Vis Sci 44 8 2003 3282 3287
40. C. Percy, E. Stanek 3rd, and L. Gloeckler Accuracy of cancer death certificates and its effect on cancer mortality statistics Am J Public Health 71 3 1981 242 250
41. I.W. McLean, and J.W. Gamel Cause-specific versus all-cause survival Ophthalmology 105 11 1998 1989 1990
42. T.K. Hakulinen, and H. Abeywickrama A computer program package for relative survival analysis Comput Programs Biomed 19 2-3 1985 197 207
43. J.A. Shields, J.J. Augsburger, L.A. Donoso, V.J. Bernardino, and M. Portenar Hepatic metastasis and orbital recurrence of uveal melanoma after 42 years Am J Ophthalmol 100 5 1985 666 668
44. A.D. Singh, C.L. Shields, and J.A. Shields Prognostic factors in uveal melanoma Melanoma Res 11 3 2001 1 9
45. J.M. Seddon, E.S. Gragoudas, K.M. Egan, R.J. Glynn, S. Howard, and R.G. Fante Relative survival rates after alternative therapies for uveal melanoma Ophthalmology 97 6 1990 769 777
46. M. Diener-West, J.D. Earle, S.L. Fine, B.S. Hawkins, C.S. Moy, and S.M. Reynolds The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS report no. 18 Arch Ophthalmol 119 7 2001 969 982
47. M.R. Speicher, G. Prescher, S. Du Manoir, A. Jauch, B. Horsthemke, and N. Bornfeld Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridisation Cancer Res 54 14 1994 3817 3823
48. G. Prescher, N. Bornfeld, H. Hirche, B. Horsthemke, K.H. Jockel, and R. Becher Prognostic implications of monosomy 3 in uveal melanoma Lancet 347 9010 1996 1222 1225
49. K. Sisley, I.G. Rennie, M.A. Parsons, R. Jacques, D.W. Hammond, and S.M. Bell Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis Genes Chromosomes Cancer 19 1 1997 22 28
50. K.A. Patel, N.D. Edmondson, F. Talbot, M.A. Parsons, I.G. Rennie, and K. Sisley Prediction of prognosis in patients with uveal melanoma using fluorescence in situ hybridisation Br J Ophthalmol 85 12 2001 1440 1444
51. M.J. Jager, H.M. Hurks, J. Levitskaya, and R. Kiessling HLA expression in uveal melanoma: there is no rule without some exception Hum Immunol 63 6 2002 444 451
52. C.M. Mooy, G.P. Luyten, P.T. de Jong, T.M. Luider, T. Stijnen, and F. van de Ham Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma Am J Pathol 147 4 1995 1097 1104
53. S.E. Coupland, G. Anastassiou, A. Stang, H. Schilling, I. Anagnostopoulos, and N. Bornfeld The prognostic value of cyclin D1, p53 and MDM2 protein expression in uveal melanoma J Pathol 191 2 2000 120 126
54. C. All-Ericsson, L. Girnita, S. Seregard, A. Bartolazzi, M.J. Jager, and O. Larsson Insulin like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target Invest Ophthalmol Vis Sci 43 1 2002 1 8
55. I. Raivio Uveal melanoma in Finland: an epidemiological, clinical, histological and prognostic study Acta Ophthalmol 133 Suppl 1977 1 64
56. I. Gislason, B. Magnusson, and H. Tulinius Malignant melanoma of the uvea in Iceland 1955-1979 Acta Ophthalmol 63 4 1985 389 394
57. J.M. Teikari, and I. Raivio Incidence of choroidal malignant melanoma in Finland in the years 1973-1980 Acta Ophthalmol 63 6 1985 661 665
58. J. Iscovich, C. Ackerman, H. Andreev, J. Pe'er, and R. Steinitz An epidemiological study of posterior uveal melanoma in Israel, 1961-1989 Int J Cancer 61 3 1995 291 295
59. Anonymous Mortality in patients with small choroidal melanoma: COMS report no. 4. The Collaborative Ocular Melanoma Study Group Arch Ophthalmol 115 7 1997 886 893
60. Anonymous The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10 Am J Ophthalmol 125 6 1998 779 796
61. C.L. Shields, J.A. Shields, M. Materin, E. Gershenbaum, A.D. Singh, and A. Smith Iris melanoma: risk factors for metastasis in 169 consecutive patients Ophthalmology 108 1 2001 172 178
62. J.M. Seddon, D.M. Albert, P.T. Lavin, and N. Robinson A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma Arch Ophthalmol 101 12 1983 1894 1899
63. C.L. Shields, J.A. Shields, P. De Potter, J. Cater, D. Tardio, and J. Barrett Diffuse choroidal melanoma: clinical features predictive of metastasis Arch Ophthalmol 114 8 1996 956 963
64. I.W. McLean, W.D. Foster, and L.E. Zimmerman Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis Hum Pathol 13 2 1982 123 132
65. H.F. Shammas, and F.C. Blodi Prognostic factors in choroidal and ciliary body melanomas Arch Ophthalmol 95 1 1977 63 69
66. M.J. McLean, W.D. Foster, and L.E. Zimmerman Prognostic factors in small malignant melanomas of choroid and ciliary body Arch Ophthalmol 95 1 1977 48 58
67. R. Folberg, V. Rummelt, R. Parys-Van Ginderdeuren, T. Hwang, R.F. Woolson, and J. Pe'er The prognostic value of tumor blood vessel morphology in primary uveal melanoma Ophthalmology 100 9 1993 1389 1398
68. P.O. de la Cruz Jr, C.S. Specht, and I.W. McLean Lymphocytic infiltration in uveal malignant melanoma Cancer 65 1 1990 112 115
69. D.M. Marcus, J.B. Minkovitz, S.D. Wardwell, and D.M. Albert The value of nucleolar organizer regions in uveal melanoma: the Collaborative Ocular Melanoma Study Group Am J Ophthalmol 110 5 1990 527 534
70. W.J. Meecham, and D.H. Char DNA content abnormalities and prognosis in uveal melanoma Arch Ophthalmol 104 11 1986 1626 1629
71. S. Seregard, M. Oskarsson, and B. Spangberg PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma Invest Ophthalmol Vis Sci 37 7 1996 1451 1458
72. A. Vaisanen, M. Kallioinen, K. von Dickhoff, L. Laatikainen, M. Hoyhtya, and T. Turpeenniemi-Hujanen Matrix metalloproteinase-2 (MMP-2) immunoreactive protein-a new prognostic marker in uveal melanoma? J Pathol 188 1 1999 56 62
73. Y. El Shabrawi, N. Ardjomand, H. Radner, and N. Ardjomand MMP9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma J Pathol 194 2 2001 201 206